When Regulation Goes Too Far: The ₹5 Lakh Lesson the Bombay High Court Just Taught the FDA
The air inside a Pune sweet shop is usually thick with the scent of simmering milk and cardamom. But for the owners of Gurunanak Dairy and Sweets, that familiar aroma was replaced by a sterile, heavy silence that lasted for over two months. For any small business owner, the sight of a government inspector isn't just a routine check; it is a moment of existential anxiety. We all demand safe food, yet we must ask: at what point does a regulator’s shield for the public become a sword against the citizen's right to earn a living?
This tension reached a breaking point recently in the Bombay High Court, where a bench of judges delivered a sharp rebuke to the Maharashtra Food and Drug Administration (FDA). The ruling wasn't just a legal victory; it was a necessary intervention against a system that had traded common sense for administrative paralysis.
The "98% Trap": Compliance Doesn't Always Mean Freedom
The nightmare for Gurunanak Dairy began on June 12, 2026. Following a food poisoning complaint, the FDA shuttered the shop, citing concerns over sanitation. In the world of bureaucracy, it is easy to flip a switch to "off," but notoriously difficult to turn it back on.
The owners didn't fight the findings; they fixed them. They filed an appeal and a compliance report almost immediately. When the FDA finally returned for a re-inspection on July 13, the shop achieved a staggering 98% compliance rating. In any reasonable world, a 98% is a definitive "A." But for the FDA, it was a ticket to nowhere. Despite the near-perfect score, the regulator refused to restore the license, leaving the shop in a state of bureaucratic purgatory.
Reflecting on this absurdity, the High Court bench noted that the FDA’s "laudable intentions" had drifted into the realm of persecution.
"We have observed that your intention is laudable and some department has at least stood up. But you are going overboard. You should have immediately revoked the suspension of the license once you noticed 98 per cent compliance."
The Massive Price of Red Tape
For a small business, time isn't just money; it’s survival. The administrative stasis imposed by the FDA between July and August created a financial hole that even a court victory couldn't entirely fill. Consider the math of this "regulatory tax" on innocence:
- ₹8.74 lakh: The total revenue lost by the shop since its closure in June.
- ₹5 lakh: The compensation amount the court ordered the FDA to pay the owners.
There is a sobering lesson in this gap. Even after winning a high-stakes legal battle, the owners are still staring at a deficit of ₹3.74 lakh. In the eyes of the law, the state was wrong, yet the business owner still pays the price for the state’s "overboard" zeal. Winning shouldn't feel like losing, but in the face of regulatory inertia, the "victory" is often partial.
"Strange and Perverse": A Judicial Reality Check
Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad did not mince words, labeling the FDA’s conduct "strange and perverse." The "perversity" the court identified lies in the distinction between regulation and punishment.
The purpose of a food safety inspection is to ensure a shop is safe for the public. Once that safety is verified—especially at a 98% threshold—the regulator’s job is done. By maintaining the suspension after compliance was achieved, the FDA transitioned from a public health guardian to a punitive master, enforcing a "strange policy" of indefinite closure. The court’s intervention was a vital reality check: power granted to ensure safety cannot be used to stifle legitimate commerce through administrative spite.
The Silent Regulator: A Pattern of Inaction
What makes this case a true study in bureaucratic failure is the proactive stance of the shop owners. They didn't hide; they sought a revocation through every available channel, including formal representations to the FDA Commissioner.
Between the July 13 re-inspection and the August 18 court ruling, the shop sat in a state of forced hibernation not because they were a threat to health, but because the regulator simply refused to act. This silence eventually forced the owners to file a Writ Petition—a heavy legal hammer used when the state fails in its basic duty.
In the aftermath, FDA Commissioner Tukaram Mundhe retreated into the safety of the "process," stating he would "examine the order" and that the agency acts "as per the law." It is a classic bureaucratic defense, but it rings hollow when contrasted with a business that was 98% compliant and 100% shuttered.
Conclusion: A Question of Balance
The ₹5 lakh fine slapped on the FDA is more than just a payment; it is a warning shot. For small businesses across Maharashtra, this ruling suggests that the "Strange Policy" of indefinite suspension may finally be coming to an end. It signals that regulators must be as efficient in restoring rights as they are in restricting them.
Public safety is the goal, but it cannot be used as a blanket excuse for administrative overreach. This case forces us to confront a fundamental question for our civic future: In our zeal to protect the public, how do we ensure we don't destroy the very livelihoods that sustain it? Where do you draw the line between necessary oversight and "perverse" interference?
